항암화학요법을 받은 유방암 환자의 인지기능 = Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy

다국어 초록 (Multilingual Abstract)

Purpose: This study reviewed articles related to breast cancer, cognitive function and chemotherapy available in 4 databases. Methods: The researcher reviewed 32 pieces of literature that were published between January 2001 and November 2011. Results: Within the last decade, several studies have investigated whether adjuvant treatment of breast cancer affects cognitive function. A number of prospective studies have reported inconsistent results regarding whether chemotherapy affects cognitive function. Approximately half of the studies reported subtle cognitive decline in a wide range of domains among some breast cancer patients following chemotherapy, and others did not. Conclusion: Breast cancer patients receiving adjuvant chemotherapy showed the most deterioration and the most persistent decline in cognitive function. Since cognitive impairment is subtle, if evident at all, discrepant findings are due to hormonal, physiological, psychological or temporal confounding variables and differences in study design. Especially, that chemotherapy may impair memory, executive function, attention and visuospatial function in women with breast cancer.

목차 (Table of Contents)

• 서론
• 연구 방법
• 연구 결과
• 논의
• 결론
• 참고문헌

참고문헌 (Reference)

1 정복례, "유방암의 위험요인" 대한종양간호학회 8 (8): 120-127, 2008

2 nal Cancer Information Center, "http : //www. ncc. re. kr [accessed on 1 July 2011]"

3 Munir F, "Women’s perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study" 19 : 1362-1370, 2010

4 Hermelink K, "Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study" 19 : 1321-1328, 2010

5 Tager FA, "The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study" 123 (123): 25-34, 2010

6 Stewart A, "The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study" 17 (17): 122-130, 2008

7 Jansen CE, "Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide" 17 : 1189-1195, 2008

8 Vearncombe KJ, "Predictors of cognitive decline after chemotherapy in breast cancer patients" 15 : 951-962, 2009

9 Yamada TH, "Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy" 22 (22): 48-54, 2010

10 Seigers R, "Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research" 35 : 729-741, 2011

11 Calvio L, "Measures of cognitive function and work in occupationally active breast cancer survivors" 52 : 219-227, 2010

12 Biglia N, "Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight" 7 (7): 1891-1900, 2010

13 Hedayati E, "Effects of adjuvant treatment on cognitive function in women with early breast cancer" 9 : 1-8, 2011

14 Quesnel C, "Cognitive impairments associated with breast cancer treatments: results from a longitudinal study" 116 (116): 113-123, 2009

15 Hurria A, "Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study" 54 : 925-931, 2006

16 Phillips KA, "Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial" 126 : 221-226, 2011

17 Debess J, "Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study" 121 (121): 91-100, 2010

18 Deprez S, "Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients" 32 : 480-493, 2011

19 Bender CM, "Chemotherapy may have small to moderate negative effects on cognitive functioning" 32 : 316-319, 2006

20 Schagen SB, "Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients" 98 : 1742-1745, 2006

21 de Ruiter MB, "Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer" 32 : 1206-1219, 2011

22 Vardy J, "Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop" 19 : 623-629, 2008

23 Vodermaier A, "Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments" 5 : 503-516, 2009

24 Ahles TA, "Breast cancer chemotherapy-related cognitive dysfunction" 3 (3): 84-90, 2002

25 Reid-Arndt SA, "Breast cancer and “chemobrain”: the consequences of cognitive difficulties following chemotherapy and the potential for recovery" 106 (106): 127-131, 2009

26 Andrykowski MA, "Attitudes toward information about genetic risk for cognitive impairment after cancer chemotherapy: breast cancer survivors compared with healthy controls" 28 : 3442-3447, 2010

27 Wefel JS, "Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer" 116 : 3348-3356, 2010

28 Jansen CE, "A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients" 19 : 1647-1656, 2011

29 Jenkins V, "A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer" 94 : 828-834, 2006